Doctors back twice-yearly HIV jab, warn it won't work for everyone

Health Cabinet Secretary Aden Duale poses with Community Health Promoters (CHPs) during the launch of the rollout of Lenacapavir drug at Riruta Health Centre, Nairobi, on February 26, 2026. (MoH, X)

Doctors have backed a new injectable drug for HIV prevention, even as they raised a red flag over the sustainability of a rollout backed almost entirely by donor funding. 

The endorsement comes at a time when global health financing is under severe strain.